What is the MLTX stock price prediction for next 2 weeks?

According to our price prediction algorithm,MoonLake Immunotherapeutics (MLTX) price will be around $15.49 in the next 2 weeks. This means it will decrease by -16.204434829637634 from the last closing price. This prediction may vary from other time period filters for MLTX stock.

What can be the highest Possible price of MLTX stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, MLTX can achieve the highest price of $16.53 which is -10.604480402748742 lower than last closing price. This prediction may vary from other time period filters for MLTX stock.

What can be the lowest Possible price of MLTX stock in next 2 weeks?

As per the forecast and algorithmic analysis, MLTX stock price can be as low as $14.52 which is -21.475185149658195 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for MLTX stock.

Will MLTX stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that MLTX stock will lose-16.204434829637634 in the next 2 weeks. This prediction may vary from other time period filters for MLTX stock.

What is MLTX stock last closing price?

Last closing price of MLTX stock was $18.49.

What is MLTX stock price prediction?

MLTX stock price prediction means predicting the future closing prices of MLTX stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of MLTX stock in a certain time period.

How we predict MLTX stock future prices?

If you are searching for MLTX stock forecast, analysis or price prediction, then you might be wondering what MoonLake Immunotherapeutics (MLTX) will do in the future. Our MLTX price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This MLTX price prediction will likely answer most of your questions.

How frequent we update MLTX stock predictions?

We are updating the forecasts for the MLTX stock on daily basis.

Is using ML forecasting for MLTX stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for MLTX stock same for all the time periods?

No, the prediction for MLTX stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

MoonLake Immunotherapeutics Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$18.4933.69%Since 2 Weeks

Predicted Price$15.49-16.2%For 2 Weeks

Upper Predicted Price$16.53-10.6%For 2 Weeks

Lower Predicted Price$14.52-21.48%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of MLTX will decline by -16.20% over the next 2 Weeks and hit $15.49 by Friday, January 23, 2026. In that time frame, MLTX's share price is expected to range between $14.52 and $16.53.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 23, 2026	16.56	17.42	18.39
Jan 22, 2026	17.29	18.13	19.01
Jan 21, 2026	16.66	17.56	18.45
Jan 20, 2026	16.70	17.62	18.60
Jan 19, 2026	16.73	17.64	18.52
Jan 16, 2026	17.10	17.96	18.83
Jan 15, 2026	17.79	18.67	19.50
Jan 14, 2026	17.25	18.09	18.99
Jan 13, 2026	17.22	18.15	19.04
Jan 12, 2026	17.22	18.17	19.12

MLTX shares rose +28.94% in Friday, January 9, 2026's trading session, rising from a previous close of $14.34 to move at $18.49. The stock demonstrated notable intraday movement (see MLTX's key stats for a full breakdown), fluctuating between $14.92 and $18.64, a +24.93% trading range. While recent weeks have seen some volatility, MLTX has managed to secure a +33.69% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 14.54M shares changing hands, 9.91M fewer than the previous session. This amounted to $268.94M in total market activity.

Will MLTX Continue Its Downward Trend?

According to analyst ratings and projections for MLTX, MoonLake Immunotherapeutics shares are anticipated to decrease by -0.54%, potentially reaching $18.39 per share by January 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for MLTX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the MLTX stock forecast, now is not the best time to buy MLTX stock because its current trading price is +6.15% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MLTX covering social and institutional perspectives.

MLTX Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into MLTX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 63.39% to 78.31%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 46.97%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.96%, maintains a neutral outlook for the long term. Insights into MLTX's shareholder base show how institutional investors are positioning themselves during these momentum shifts

MoonLake Immunotherapeutics Short-Term Forecasts

MLTX Forecast For Next 5 Days

Our algorithm anticipates MoonLake Immunotherapeutics (MLTX) stock could hit $15.16 by Jan 08, 2026. This represents a -18.02% rise from today's price, following a +8.80% change over the past five days.

MLTX Forecast For Next 30 Days

Based on analysis of market trends, the outlook for MoonLake Immunotherapeutics (MLTX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $13.89, which would mean a -24.88% decrease from the current price of $18.49. Projections for this period range from a high of $15.99 to a low of $12.18.

MLTX Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for MoonLake Immunotherapeutics's price over the next three months point to a drop. MLTX stock is expected to peak at $14.20 on Jan 12, 2026 before potentially dipping to $0.00 on Apr 10, 2026. On average, MLTX is likely to trade around $3.90 in the coming 90 days.

MoonLake Immunotherapeutics Stock Forecast 2025

Based on our predictive models, MoonLake Immunotherapeutics (MLTX) is expected to trade between $0.00 and $18.26 throughout 2026. This would result in an average price of $1.35, potentially offering investors a -92.70% return from current levels.

MoonLake Immunotherapeutics Monthly Forecast 2026

January 2026

According to our latest forecast models, MoonLake Immunotherapeutics (MLTX) is positioned to show a strong performance in January 2026. The price is predicted to move between $4.51 and $18.26, settling at an average of $10.45. This could translate to a -43.48% loss.

February 2026

Based on current market signals, MoonLake Immunotherapeutics is projected to trend february 2026. We forecast a trading range from $0.13 to $8.41, with a likely average price of $4.15. Investors could expect a potential return of -77.56%.

March 2026

Our predictive algorithms indicate MoonLake Immunotherapeutics stock may see a shift in March 2026. The expected range spans $0.00–$4.46, with an average target of $1.40. This represents a cautious outlook and a possible loss of -92.43%.

April 2026

Analyzing established trends, MoonLake Immunotherapeutics looks set to move in April 2026. Projections place the stock between $0.00 and $3.23, averaging around $0.51. This suggests a -97.24% loss from current levels.

May 2026

Market indicators suggest MoonLake Immunotherapeutics could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $2.78, with a midpoint forecast of $0.18. The stock might deliver a -99.03% loss.

June 2026

Forecasting for June 2026, models estimate that MoonLake Immunotherapeutics may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.54, averaging $0.07. This signals a cautious trajectory with potential returns around -99.62%.

July 2026

According to our latest forecast models, MoonLake Immunotherapeutics (MLTX) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $2.46, settling at an average of $0.02. This could translate to a -99.89% loss.

August 2026

Based on current market signals, MoonLake Immunotherapeutics is projected to trend august 2026. We forecast a trading range from $0.00 to $2.97, with a likely average price of $0.01. Investors could expect a potential return of -99.95%.

September 2026

Our predictive algorithms indicate MoonLake Immunotherapeutics stock may see a shift in September 2026. The expected range spans $0.00–$2.39, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.

October 2026

Analyzing established trends, MoonLake Immunotherapeutics looks set to move in October 2026. Projections place the stock between $0.00 and $2.78, averaging around $0.00. This suggests a -100.00% loss from current levels.

November 2026

Market indicators suggest MoonLake Immunotherapeutics could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $2.52, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.

December 2026

Forecasting for December 2026, models estimate that MoonLake Immunotherapeutics may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.66, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.

MLTX's history of dividends and stock splits also plays a role in long-term investor confidence.